Eli Lilly Bets Big on India’s Obesity & Diabetes Crisis with Mounjaro (tirzepatide) Launch
Eli Lilly has introduced its diabetes and weight-loss medication, Mounjaro (tirzepatide), to the Indian market following approval from the Central Drugs Standard Control Organisation (CDSCO). This launch addresses India’s escalating obesity and diabetes rates, offering a novel treatment option for patients. Understanding Mounjaro Mounjaro is a once-weekly injectable prescription medicine designed to manage type … Read more